Voloridge Investment Management
CSTL icon

Voloridge Investment Management’s Castle Biosciences CSTL Stock Holding History

Voloridge Investment Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-67,432
Closed -$1.76M – 1471
2022
Q3 		$1.76M Sell
67,432
-49,185
-42% -$1.38M 0.01% 1018
2022
Q2 		$2.56M Buy
+116,617
New +$2.71M 0.01% 941
2021
Q4 		– Sell
-18,169
Closed -$1.21M – 1613
2021
Q3 		$1.21M Buy
+18,169
New +$1.28M 0.01% 1223
2021
Q2 		– Sell
-41,070
Closed -$2.81M – 1629
2021
Q1 		$2.81M Buy
41,070
+5,692
+16% +$428K 0.02% 691
2020
Q4 		$2.38M Buy
35,378
+7,605
+27% +$412K 0.02% 668
2020
Q3 		$1.43M Buy
+27,773
New +$1.24M 0.01% 825

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Voloridge Investment Management's CSTL Position: Q4 2022 in Review

Voloridge Investment Management sold out of Castle Biosciences (CSTL) in Q4 2022, closing a stake of 67,432 shares — an estimated $1.76M sold.

Voloridge Investment Management first reported a position in CSTL in Q3 2020 and held it in 6 quarters. The position peaked at $2.81M in Q1 2021. 153 funds tracked by Wall St. Rank hold CSTL as of Q4 2022.

  • Voloridge Investment Management reported no remaining Castle Biosciences position as of Q4 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 67,432 Castle Biosciences shares in Q4 2022, an estimated $1.76M.
  • Voloridge Investment Management first reported a position in Castle Biosciences in Q3 2020 and held it in 6 quarters.
  • Voloridge Investment Management's Castle Biosciences position peaked at $2.81M in Q1 2021.
  • 153 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2022.

Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.